These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 118957)

  • 41. Comparative in-vitro activity of quinupristin/dalfopristin (RP 59500) tested against penicillin-and macrolide-resistant pneumococci by the Etest.
    Biedenbach D; Wanger A; Jones RN
    J Antimicrob Chemother; 1996 Sep; 38(3):553-5. PubMed ID: 8889731
    [No Abstract]   [Full Text] [Related]  

  • 42. [Sensitivity to staphylomycin of the bacterial flora isolated from expectorate in the course of various bronchopneumopathies].
    Gialdroni Grassi G; Fornaroli E
    G Ital Chemioter; 1967; 14(1):70-4. PubMed ID: 4908139
    [No Abstract]   [Full Text] [Related]  

  • 43. Combination effect of piperacillin with four aminoglycosides on nonfermenting gram-negative bacteria.
    Daschner F; Langmaack H; Grehn M; Steffens A; Just M
    Chemotherapy; 1981; 27(1):39-43. PubMed ID: 6452252
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro synergistic effect of doxycycline & ofloxacin in combination with ethanolic leaf extract of Vangueria spinosa against four pathogenic bacteria.
    Chatterjee SK; Bhattacharjee I; Chandra G
    Indian J Med Res; 2009 Oct; 130(4):475-8. PubMed ID: 19942754
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug interaction of promethazine & other non-conventional antimicrobial chemotherapeutic agents.
    Chakrabarty AN; Acharya DP; Neogi D; Dastidar SG
    Indian J Med Res; 1989 Jul; 89():233-7. PubMed ID: 2807428
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Further bacteriological evaluation of virginiamycin.
    Van Dijck PJ
    Chemotherapy; 1969; 14(5):322-32. PubMed ID: 4902789
    [No Abstract]   [Full Text] [Related]  

  • 47. Fortimicins A and B, new aminoglycoside antibiotics. IV. In vitro study of fortimicin A compared with other aminoglycosides.
    Girolami RL; Stamm JM
    J Antibiot (Tokyo); 1977 Jul; 30(7):564-70. PubMed ID: 19409
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Design and evaluation of an opacimetric method for determining the in vitro antibiotic sensitivity of Mycoplasma bovis].
    Poumarat F; Martel JL
    Ann Rech Vet; 1989; 20(2):135-43. PubMed ID: 2751227
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro activity of quinupristin/dalfopristin, RP59500, against gram-positive clinical isolates.
    Qadri SM; Ueno Y; Abu Mostafa FM; Halim M
    Chemotherapy; 1997; 43(2):94-9. PubMed ID: 9084917
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Antibacterial activity of species of the genus Allium].
    Didry N; Pinkas M; Dubreuil L
    Pharmazie; 1987 Oct; 42(10):687-8. PubMed ID: 3438321
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.
    Romani AA; Baroni MC; Taddei S; Ghidini F; Sansoni P; Cavirani S; Cabassi CS
    J Pept Sci; 2013 Sep; 19(9):554-65. PubMed ID: 23893489
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In-vitro activity of quinupristin/dalfopristin compared with other widely used antibiotics against strains isolated from patients with endocarditis.
    Mouton JW; Endtz HP; den Hollander JG; van den Braak N; Verbrugh HA
    J Antimicrob Chemother; 1997 May; 39 Suppl A():75-80. PubMed ID: 9511068
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclic dipeptides exhibit synergistic, broad spectrum antimicrobial effects and have anti-mutagenic properties.
    Rhee KH
    Int J Antimicrob Agents; 2004 Nov; 24(5):423-7. PubMed ID: 15519471
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PS-5, a new beta-lactam antibiotic. III. Synergistic effects and inhibitory activity against a beta-lactamase.
    Okamura K; Sakamoto M; Fukagawa Y; Ishikura T; Lein J
    J Antibiot (Tokyo); 1979 Apr; 32(4):280-6. PubMed ID: 381269
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rapid evaluation of the antibiotic susceptibility of fuel ethanol contaminant biofilms.
    Rich JO; Leathers TD; Nunnally MS; Bischoff KM
    Bioresour Technol; 2011 Jan; 102(2):1124-30. PubMed ID: 20855199
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antimicrobial peptide pleurocidin synergizes with antibiotics through hydroxyl radical formation and membrane damage, and exerts antibiofilm activity.
    Choi H; Lee DG
    Biochim Biophys Acta; 2012 Dec; 1820(12):1831-8. PubMed ID: 22921812
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro activity and post-antibiotic effect of quinupristin/dalfopristin (Synercid).
    Ling TK; Fung KS; Cheng AF
    Chemotherapy; 2001; 47(4):243-9. PubMed ID: 11399860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inducible resistance to macrolides, lincosamides and streptogramin type B antibiotics: the resistance phenotype, its biological diversity, and structural elements that regulate expression--a review.
    Weisblum B
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():63-90. PubMed ID: 3932311
    [No Abstract]   [Full Text] [Related]  

  • 59. In vitro bactericidal activity and post-antibiotic effect of dactimicin, a new aminoglycoside, alone and in combination with other antibiotics.
    Debbia EA; Schito GC; Stefani S; Nicoletti G
    Drugs Exp Clin Res; 1989; 15(3):125-8. PubMed ID: 2752911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro synergism of nalidixic acid with other broad spectrum antibiotics.
    Piccolomini R; Cellini L; Allocati N; Ravagnan G
    Chemioterapia; 1984 Apr; 3(2):103-7. PubMed ID: 6532536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.